Purchase Order 75N91020P00974

<p>The National Cancer Institute awarded a purchase order to Bulldog Bio, Inc. for $15,995.00 on September 22, 2020, for electroporating equipment necessary to perform in vitro experiments with live mouse embryos. Performance is located in Portsmouth, New Hampshire, with an ultimate completion date of October 21, 2020. The order carries firm fixed-price terms and no set-aside designation.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Bulldog Bio, Inc. for $17,601.50 on August 6, 2020, with ultimate completion the same date. The order procures an electroporation system to introduce mRNA into oocyte cells for research performed by Takashi Akera. Place of performance is Portsmouth, New Hampshire. Pricing is firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Biocytogen LLC for $10,000.00 on April 3, 2018. Work is performed in Worcester, Massachusetts. The order carries a firm fixed price for commercial items, with ultimate completion on May 3, 2018. No small business set-aside was applied.</p>

This contract award to Bulldog Bio, Inc. is for the purchase of an electro kinetic transfer system by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the U.S. Department of Health and Human Services. The fixed-price purchase order, valued at $16,995.00, does not have a set-aside designation. Bulldog Bio, a for-profit organization, has received multiple prior federal contract awards from various NIH entities and the U.S. Department of Agriculture to...

<p>The National Human Genome Research Institute awarded a purchase order to Bulldog Bio, Inc. for $15,222.20 on December 7, 2017, with final completion due November 30, 2018. No small business set-aside applies. Work is performed in Bethesda, Maryland. The order is for advanced laboratory equipment and scientific research technologies, specifically electroporation and gene editing systems supporting genomic research operations.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biologicals valued at $13,401.67 on March 12, 2020, with an ultimate completion date of April 9, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to New England Biolabs, Inc. for $10,680.00 on September 5, 2018, with an ultimate completion date of October 5, 2018. Performance occurs in Bethesda, Maryland. The order is a firm fixed price purchase of molecular biology products, reagents, and research supplies. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $13,879.50 in biological kits, with an award date of June 13, 2019 and completion date of July 13, 2019. Place of performance is Carlsbad, California. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to New England Biolabs, Inc. for $10,680.00 on August 1, 2018. Performance is in Bethesda, Maryland. The order covers molecular biology products, reagents, and kits for life sciences research. The contract is firm fixed price with an ultimate completion date of September 1, 2018.</p>

<p>The National Cancer Institute issued a purchase order to The Broad Institute, Inc. for $13,480.01 on January 24, 2019, for custom lab work on a genomics platform. Work is performed in Cambridge, Massachusetts. The order is firm fixed-price with an ultimate completion date of July 25, 2019. No set-aside was used.</p>